Tuesday, August 28, 2018 7:39:09 PM
the special PP private interest want to see efficacy at 50 patients lets say if the trial goes in 2 cohorts.
Also those guys didn't want warrants under their own holdings.. so .50 is a minimum now..
the most significant data is 6 months in predicting 12.. and is the retreatment interval for Phase 2.
Therefore 'maximum' confidence can be ascertained at an 'intermediate-endpoints'
which is what Dr.Gottlieb speaks about when discussing small companies with trials with outsized results that are over and above expectations regardign 'Cures Act'
The same NIH institution that funded Dr.McFarland 3.2/5 years Dr.Collins is Director who presents with Dr.Gottlieb.. so we forsure have attention cross border in top medical spots.
This trial is designed for out maximum-success potential.. IMO after watching the AGM
The path seems clear to me with this logic. (but hey) i didn't make money with pot or crypto so IMHO...
Hopefully we can get a nice 2018 run
GRO3 INFORMATION
Love stocks that have; Revenues, No Toxic Debts & Innovative
project ambitions.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM